RGT 0.00% 30.0¢ argent biopharma limited

Ann: Annual Report to shareholders, page-2

  1. 13,769 Posts.
    lightbulb Created with Sketch. 2317
    Still seeing big annual losses of $15mil - revenue up to $3mil - but only an increase from last year of less than $1mil. Good signs but not overly dramatic.

    Cash and receivables less than $8mil. Question on where operating capital will come from this financial year - sales would need to go up 500% just to cover costs based on current levels.

    MXC will really need to hit the dot with revenue over the next 12 months.

    Worrying sign for share holders is the the SP is now stubbornly well below the psychological figure of 6 cents. 6 cents would be the entry point for most investors.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $14.52M
Open High Low Value Volume
28.5¢ 30.0¢ 28.5¢ $290 1.008K

Buyers (Bids)

No. Vol. Price($)
1 1456 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 2307 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.